Tag Archives: NYSE:PFE

Pfizer (PFE) Gets a Buy Rating from Cantor Fitzgerald

In a report released today, Louise Chen from Cantor Fitzgerald reiterated a Buy rating on Pfizer (PFE – Research Report), with a price target of $53. The company’s shares opened today at $44.08. Chen noted: “We reiterate our OW and

Pfizer (PFE) Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Louise Chen reiterated a Buy rating on Pfizer (NYSE: PFE) today and set a price target of $53. The company’s shares closed yesterday at $43.93, close to its 52-week high of $45.81. Chen wrote: “. We reiterate

Pfizer (PFE) Gets a Hold Rating from Barclays

Barclays analyst Geoff Meacham maintained a Hold rating on Pfizer (NYSE: PFE) today and set a price target of $40. The company’s shares opened today at $43.68, close to its 52-week high of $44.46. According to TipRanks.com, Meacham is a

Cantor Fitzgerald Believes Pfizer (NYSE: PFE) Still Has Room to Grow

In a report released yesterday, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Pfizer (NYSE: PFE), with a price target of $45. The company’s shares closed yesterday at $42.85, close to its 52-week high of $42.92. Chen said:

Credit Suisse Maintains Their Hold Rating on Pfizer (PFE)

In a report released today, Vamil Divan from Credit Suisse maintained a Hold rating on Pfizer (NYSE: PFE), with a price target of $40. The company’s shares opened today at $41.78, close to its 52-week high of $42.77. According to

Pfizer (PFE) Gets a Hold Rating from Goldman Sachs

In a report released today, Jami Rubin from Goldman Sachs maintained a Hold rating on Pfizer (NYSE: PFE), with a price target of $45. The company’s shares opened today at $41.50, close to its 52-week high of $42.77. According to